Topical Agents Containing Magnesium Sulfate & Wound Healing in the Rat Model
Study Details
Study Description
Brief Summary
An experimental study examining wound healing in 5 different groups on 30 rats.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Early Phase 1 |
Detailed Description
Magnesium topically increases collagen synthesis and angiogenesis, providing faster and higher quality wound healing. In addition, with its analgesic effect, it will also eliminate the pain sensation caused by the wound and increase the quality of life of the patient whose skin integrity is impaired.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Group placebo Isotonic solution will be administered daily to 6 female rats. |
Other: placebo comparator
solution containing 0.9 % sodium chlorine
|
Sham Comparator: Group sham Base cream to be applied twice a day to 6 female rats. |
Other: sham comparator
vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
|
Experimental: Group %1 mgso4 Cream containing 1% MgSO4 will be applied twice a day to 6 female rats. |
Other: Experimental drug 1
A cream containing 10 % MgSO4.vaseline, beeswaxpolyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
|
Experimental: Group %10 MgSO4 Cream containing 10% MgSO4 will be applied twice a day to 6 female rats. |
Other: Experimental drug 2
A cream containing 10 % MgSO4.vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water
|
Active Comparator: Group positive control Cream containing centella asiatica will be applied twice a day to 6 female rats. |
Drug: Centella asiatica
A cream containing Centella asiatica
|
Outcome Measures
Primary Outcome Measures
- 7th day evaluation [7th day]
Histopathological evaluation of wound healing comparing with the rate of vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta) and hydroxyproline at immunohistochemical staining with biopsy on the 7th day.
Secondary Outcome Measures
- 15th day evaluation [15th day]
Histopathological evaluation of wound healing comparing with the rate of VEGF, TGF-beta and hydroxyproline at immunohistochemical staining with biopsy on the 15th day.
Eligibility Criteria
Criteria
Inclusion Criteria:
- healthy rats between ages of 8- 12 weeks
Exclusion Criteria:
- weight loss of more than 15% of body weight
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Başakşehir Çam Ve Sakura Hospital | Istanbul | Turkey |
Sponsors and Collaborators
- Basaksehir Cam & Sakura Şehir Hospital
- Istanbul Kent University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SakuraDermatology1